Epitopea
Transatlantic cancer immunotherapeutics company.
| GBP | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 474 % |
| EBITDA | 0000 | 0000 |
| % EBITDA margin | (3342 %) | (928 %) |
| Profit | 0000 | 0000 |
| % profit margin | (3035 %) | (873 %) |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads